IRWD vs SLB · P/E 5.7, rev $219.5M vs P/E 12, rev $8.97B
Ironwood Pharmaceuticals Inc (IRWD) versus Schlumberger NV (SLB) — a side-by-side from cached financials, not a winner call.
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US.
Latest reported IRWD revenue for 2026-06-30 was $219.5M. Net income was $92.1M. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
Latest reported SLB revenue for 2026-06-30 was $8.97B. Net income was $786.0M. Revenue was up 2.9% from 2026-03-31 to 2026-06-30. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
IRWD currently screens at market cap $579.4M and trailing P/E 5.7. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Not investment advice. Open the IRWD and SLB stock pages for the full models.
Not investment advice.